Obesity and Coronary Risk in Patients Treated With Second-Generation Antipsychotics

Por Correll, Christoph U., Kane, John M, Manu, Peter
Publicado em 2010

Sudden Deaths in Psychiatric Patients

Por Manu, Peter, Kane, John M., Correll, Christoph U.
Publicado em 2011

Does Antipsychotic Polypharmacy Increase the Risk for Metabolic Syndrome?

Por Correll, Christoph U., Frederickson, Anne M., Kane, John M., Manu, Peter
Publicado em 2006

Antipsychotic Drug Administration Does Not Correlate with Prolonged Rate-Corrected QT Interval in Children and Adolescents: Results from a Nested Case–Control Study

Por Correll, Christoph U., Harris, Jennifer, Figen, Vicki, Kane, John M., Manu, Peter
Publicado em 2011

When Can Patients with Potentially Life-Threatening Adverse Effects Be Rechallenged with Clozapine? A Systematic Review of the Published Literature

Por Manu, Peter, Sarpal, Deepak, Muir, Owen, Kane, John M., Correll, Christoph U.
Publicado em 2011

Osteoporosis and fracture risk in people with schizophrenia

Por Kishimoto, Taishiro, De Hert, Marc, Carlson, Harold E., Manu, Peter, Correll, Christoph U.
Publicado em 2012

Cardiometabolic Risk of Second-Generation Antipsychotics During First-Time Use in Children and Adolescents

Por Correll, Christoph U., Manu, Peter, Olshanskiy, Vladimir, Napolitano, Barbara, Kane, John M., Malhotra, Anil K.
Publicado em 2009

Dysmetabolic Signals in “Metabolically Healthy” Obesity

Por Manu, Peter, Ionescu-Tirgoviste, Constantin, Tsang, James, Napolitano, Barbara A., Lesser, Martin L., Correll, Christoph U.
Publicado em 2012

QT Interval Duration and Dispersion in Children and Adolescents Treated With Ziprasidone

Por Correll, Christoph U., Lops, Johnny D., Figen, Vicki, Malhotra, Anil K., Kane, John M., Manu, Peter
Publicado em 2011

Markers of inflammation in schizophrenia: association vs. causation

Por Manu, Peter, Correll, Christoph U, Wampers, Martien, Mitchell, Alex J, Probst, Michel, Vancampfort, Davy, De Hert, Marc
Publicado em 2014

Which clinical and biochemical predictors should be used to screen for diabetes in patients with serious mental illness receiving antipsychotic medication? A large observational st...

Por Mitchell, Alex J., Vancampfort, Davy, Manu, Peter, Correll, Christoph U., Wampers, Martien, van Winkel, Ruud, Yu, Weiping, De Hert, Marc
Publicado no PLoS One (2019)

Effectiveness of a Cognitive Behavioral Weight Management Intervention in Obese Patients with Psychotic Disorders Compared to Patients with Non-Psychotic Disorders or No Psychiatri...

Por Zhang, Jian-Ping, Weiss, Jeffrey J., McCardle, Melissa, Klopchin, Hope, Rosendahl, Eileen, Maayan, Lawrence, Convit, Antonio, Kane, John M, Manu, Peter, Correll, Christoph U
Publicado em 2012

RISK OF CARDIOVASCULAR DISEASE MORBIDITY AND MORTALITY IN FRAIL AND PRE-FRAIL OLDER ADULTS: RESULTS FROM A META-ANALYSIS AND EXPLORATORY META-REGRESSION ANALYSIS

Por Veronese, Nicola, Cereda, Emanuele, Stubbs, Brendon, Solmi, Marco, Luchini, Claudio, Manzato, Enzo, Sergi, Giuseppe, Manu, Peter, Harris, Tamara, Fontana, Luigi, Strandberg, Timo, Amieva, Helene, Dumurgier, Julien, Elbaz, Alexis, Tzourio, Christophe, Eicholzer, Monika, Rohrmann, Sabine, Moretti, Claudio, D’Ascenzo, Fabrizio, Quadri, Giorgio, Polidoro, Alessandro, Lourenço, Roberto Alves, Moreira, Virgilio Garcia, Sanchis, Juan, Scotti, Valeria, Maggi, Stefania, Correll, Christoph U.
Publicado no Ageing Res Rev (2017)